From MedscapeCME Clinical Briefs; News Author: Laurie Barclay, MD
November 23, 2010 — Watchful waiting or active surveillance are options in selected patients with benign prostatic hyperplasia (BPH) and prostate cancer, according to a review reported in the December issue of the International Journal of Clinical Practice.
